Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:33634092

A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients.

Zewei Tu · Lei Shu · Jingying Li · Lei Wu · Chuming Tao · Minhua Ye · Xingen Zhu · Kai Huang

Frontiers in cell and developmental biology · 2020 doi:10.3389/fcell.2020.588368

Paper

complete

Experiment

partial

Data

partial

Analysis

complete

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:33634092
kind
science-record
content_hash
sha256:ccd6b4640759d1661fc02db19e997d7b4913d421982246916444b545a4be0d0f
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:41:26Z
updated_at
2026-11-01T22:03:12Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients.
doi
10.3389/fcell.2020.588368
pmid
33634092
authors array · 8 items
[0]
Zewei Tu
[1]
Lei Shu
[2]
Jingying Li
[3]
Lei Wu
[4]
Chuming Tao
[5]
Minhua Ye
[6]
Xingen Zhu
[7]
Kai Huang
journal
Frontiers in cell and developmental biology
year
2020
abstract
RNA binding proteins (RBPs) have been reported to be involved in cancer malignancy but related functions in glioma have been less studied. Herein, we screened 14 prognostic RBP genes and constructed a risk signature to predict the prognosis of glioma patients. Univariate Cox regression was used to identify overall survival (OS)-related RBP genes. Prognostic RBP genes were screened and used to establish the RBP-signature using the least absolute shrinkage and selection operator (Lasso) method in The Cancer Genome Atlas (TCGA) cohort. The 14 RBP genes signature showed robust and stable prognostic value in the TCGA training (n = 562) cohort and in three independent validation cohorts (Chinese Glioma Genome Atlas [CGGA]seq1, CGGAseq2, and GSE16011 datasets comprising 303, 619, and 250 glioma patients, respectively). Risk scores were calculated for each patient and high-risk gliomas were defined by the median risk score in each cohort. Survival analysis in subgroups of glioma patients showed that the RBP-signature retained its prognostic value in low-grade gliomas (LGGs) and glioblastomas (GBM)s. Univariate and multivariate Cox regression analysis in each dataset and the meta cohort revealed that the RBP-signature stratification could efficiently recognize high-risk gliomas [Hazard Ratio (HR):3.662, 95% confidence interval (CI): 3.187-4.208, p < 0.001] and was an independent prognostic factor for OS (HR:1.594, 95% CI: 1.244-2.043, p < 0.001). Biological process and KEGG pathway analysis revealed the RBP gene signature was associated with immune cell activation, the p53 signaling pathway, and the PI3K-Akt signaling pathway and so on. Moreover, a nomogram model was constructed for clinical application of the RBP-signature, which showed stable predictive ability. In summary, the RBP-signature could be a robust indicator for prognostic evaluation and identifying high-risk glioma patients.
claims array · 2 items
[0] object · 6 fields
id
claim-method
statement
As the training cohort, TCGA dataset was used to conduct univariate Cox regression analysis to screen for OS-related RBP genes in gliomas. A total of 662 OS-related RBP genes were identified (p < 0.05). Next, Lasso Cox regression method, a recommended method for regression of high-dimensional microarray data, was used to fit the OS-related RBPs data and construct a risk signature based on the selected 662 RBP genes.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:33634092
locator
sections[6] "Construction of the RBP-Signature" paragraph 2
quote
As the training cohort, TCGA dataset was used to conduct univariate Cox regression analysis to screen for OS-related RBP genes in gliomas. A total of 662 OS-related RBP genes were identified (p < 0.05). Next, Lasso Cox regression method, a recommended method for regression of high-dimensional microarray data, was used to fit the OS-related RBPs data and construct a risk signature based on the selected 662 RBP genes.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
Publicly available datasets were analyzed in this study. This data can be found here: The data analyzed in this study can be acquired in the TCGA (http://cancergenome.nih.gov/), CGGA (http://www.cgga.org.cn/), and GEO (https://www.ncbi.nlm.nih.gov/geo/) websites.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:33634092
locator
sections[20] "Data Availability Statement" paragraph 2
quote
Publicly available datasets were analyzed in this study. This data can be found here: The data analyzed in this study can be acquired in the TCGA (http://cancergenome.nih.gov/), CGGA (http://www.cgga.org.cn/), and GEO (https://www.ncbi.nlm.nih.gov/geo/) websites.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
partial
objective
null
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:33634092
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
blocked
blocked_on
data:accession_absent
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 1 item
[0]
step:obtain_source_data blocked on data:accession_absent
data object · 3 fields
state
partial
assets array · 3 items
[0] object · 15 fields
id
source:pmid:33634092
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.3389/fcell.2020.588368
sha256
sha256:be85b9d7dc3ce7962a39d8c0ae2fcc3d31ebe4c72364cefa3f9268c5a6d8d06d
bytes
33399
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.3389/fcell.2020.588368
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC7901892
source
europe_pmc_fulltext
coverage
whole_body_without_references
text_hash_scope
rendered_section_body
[1] object · 16 fields
id
asset:table:pmid:33634092:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:6108ddace2d5cff7a6dd995ffdc1891020d14c9eb11012c2c33fbc22ffdbe2ff
bytes
2285
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[4]/table-wrap[1]#T1
version
null
note
Clinicopathological and molecular information of glioma patients included in this study.
structure object · 5 fields
pmcid
PMC7901892
section_index
4
section_title
Patient Exclusion Criterion
row_count
31
column_count
6
table object · 8 fields
label
Table 1
caption
Clinicopathological and molecular information of glioma patients included in this study.
rows array · 31 items
[0] array · 6 items
[0]
Features
[1]
Total
[2]
TCGA cohort
[3]
CGGAseq1 cohort
[4]
CGGAseq2 cohort
[5]
GSE16011 cohort
[1] array · 6 items
[0]
[1]
(n = 1,734)
[2]
(n = 562)
[3]
(n = 303)
[4]
(n = 619)
[5]
(n = 250)
[2] array · 1 item
[0]
Overall survival (years)
[3] array · 6 items
[0]
Median (range)
[1]
1.54 (0.08–20.68)
[2]
1.18 (0.08–17.34)
[3]
2.22 (0.09–11.41)
[4]
2.16 (0.11–11.98)
[5]
1.27 (0.08–20.68)
[4] array · 6 items
[0]
<5
[1]
1,428 (82.4%)
[2]
512 (91.1%)
[3]
201 (66.3%)
[4]
509 (82.2%)
[5]
206 (82.4%)
[5] array · 6 items
[0]
≥5
[1]
306 (17.6%)
[2]
50 (8.9%)
[3]
102 (33.7)
[4]
110 (69%)
[5]
44 (17.6%)
[6] array · 1 item
[0]
Age (years)
[7] array · 6 items
[0]
Median (range)
[1]
45 (8–87)
[2]
47.5 (14–87)
[3]
42 (8–79)
[4]
43 (11–76)
[5]
51.5 (14–81)
[8] array · 6 items
[0]
<40
[1]
617 (35.6%)
[2]
197 (35.1%)
[3]
119 (39.3%)
[4]
235 (38.0%)
[5]
66 (26.4%)
[9] array · 6 items
[0]
≥40
[1]
1,115 (64.3%)
[2]
365 (64.9%)
[3]
184 (60.7%)
[4]
383 (61.9%)
[5]
183 (73.2%)
[10] array · 6 items
[0]
NA
[1]
2 (0.1%)
[2]
0 (0.0%)
[3]
0 (0.0%)
[4]
1 (0.2%)
[5]
1 (0.4%)
[11] array · 1 item
[0]
Gender
[12] array · 6 items
[0]
Male
[1]
1,035 (59.7%)
[2]
326 (58.0%)
[3]
187 (61.7%)
[4]
356 (57.5%)
[5]
166 (66.4%)
[13] array · 6 items
[0]
Female
[1]
699 (40.3%)
[2]
236 (42.0%)
[3]
116 (38.3%)
[4]
263 (43.5%)
[5]
84 (33.6%)
[14] array · 1 item
[0]
WHO grade
[15] array · 6 items
[0]
II
[1]
488 (28.1%)
[2]
196 (34.9%)
[3]
97 (32.0%)
[4]
173 (27.9%)
[5]
22 (8.8%)
[16] array · 6 items
[0]
III
[1]
598 (34.5%)
[2]
212 (37.7%)
[3]
73 (24.1%)
[4]
232 (37.5%)
[5]
81 (32.4%)
[17] array · 6 items
[0]
IV
[1]
648 (37.4%)
[2]
154 (27.4%)
[3]
133 (43.9%)
[4]
214 (34.6)
[5]
147 (58.8%)
[18] array · 1 item
[0]
Histology
[19] array · 6 items
[0]
Astrocytoma
[1]
401 (23.1%)
[2]
150 (26.7%)
[3]
62 (20.5%)
[4]
163 (26.3%)
[5]
26 (10.4%)
[20] array · 6 items
[0]
Oligoastrocytoma
[1]
414 (23.9%)
[2]
102 (18.1%)
[3]
72 (23.8%)
[4]
213 (34.4%)
[5]
27 (10.8%)
[21] array · 6 items
[0]
Oligodendroglioma
[1]
271 (15.6%)
[2]
156 (27.8%)
[3]
36 (11.9%)
[4]
29 (4.7%)
[5]
50 (20.0%)
[22] array · 6 items
[0]
Glioblastoma
[1]
648 (37.4%)
[2]
154 (27.4%)
[3]
133 (43.9%)
[4]
214 (34.6%)
[5]
147 (58.8%)
[23] array · 1 item
[0]
IDH mutation status
[24] array · 6 items
[0]
6 Mutant
[1]
823 (47.5%)
[2]
342 (60.9%)
[3]
165 (54.5%)
[4]
316 (51.1%)
[5]
NA
[25] array · 6 items
[0]
Wild
[1]
304 (17.5%)
[2]
212 (37.7%)
[3]
137 (45.2%)
[4]
258 (41.7%)
[5]
NA
[26] array · 6 items
[0]
NA
[1]
607 (35.0%)
[2]
8 (1.4%)
[3]
1 (0.3%)
[4]
45 (7.3%)
[5]
NA
[27] array · 1 item
[0]
1p/19q codeletion status
[28] array · 6 items
[0]
Non-codeletion
[1]
1,080 (62.3%)
[2]
418 (74.4%)
[3]
235 (77.6%)
[4]
427 (69.0%)
[5]
NA
[29] array · 6 items
[0]
Codeletion
[1]
329 (19.0%)
[2]
138 (24.6%)
[3]
63 (20.8%)
[4]
128 (20.7%)
[5]
NA
[30] array · 6 items
[0]
NA
[1]
325 (18.7%)
[2]
6 (1.1%)
[3]
5 (1.7%)
[4]
64 (10.3%)
[5]
NA
locator
section[4]/table-wrap[1]#T1
[2] object · 16 fields
id
asset:table:pmid:33634092:2
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:5a707bb2f8d918ebd5241aaebf23477b7380ed191d019ca0c243c4deb58360a3
bytes
1690
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[15]/table-wrap[1]#T2
version
null
note
Coeffients and univariate Cox regression analysis of 14 RBP genes.
structure object · 5 fields
pmcid
PMC7901892
section_index
15
section_title
The Prognostic Value and Expression Levels of the 14 RBPs in Gliomas
row_count
15
column_count
7
table object · 8 fields
label
Table 2
caption
Coeffients and univariate Cox regression analysis of 14 RBP genes.
rows array · 15 items
[0] array · 7 items
[0]
Gene
[1]
Coeffients
[2]
Description
[3]
HR
[4]
HR.95L
[5]
HR.95H
[6]
p-value
[1] array · 7 items
[0]
CTIF
[1]
−0.002890097
[2]
CBP80/20-dependent translation initiation factor
[3]
0.953
[4]
0.944
[5]
0.961
[6]
<0.001
[2] array · 7 items
[0]
GNL1
[1]
−0.00776999
[2]
Guanine nucleotide binding protein-like 1
[3]
0.965
[4]
0.959
[5]
0.971
[6]
<0.001
[3] array · 7 items
[0]
ANG
[1]
0.007044793
[2]
Angiogenin, ribonuclease, RNase A family, 5
[3]
1.083
[4]
1.068
[5]
1.099
[6]
<0.001
[4] array · 7 items
[0]
APOBEC3F
[1]
0.016648735
[2]
Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
[3]
1.307
[4]
1.256
[5]
1.360
[6]
<0.001
[5] array · 7 items
[0]
CARHSP1
[1]
0.0000186
[2]
Calcium regulated heat stable protein 1
[3]
1.024
[4]
1.019
[5]
1.029
[6]
<0.001
[6] array · 7 items
[0]
FBXO17
[1]
0.02126961
[2]
F-box protein 17
[3]
1.071
[4]
1.060
[5]
1.082
[6]
<0.001
[7] array · 7 items
[0]
ISG20
[1]
0.024346644
[2]
Interferon stimulated exonuclease gene 20kDa
[3]
1.173
[4]
1.143
[5]
1.203
[6]
<0.001
[8] array · 7 items
[0]
KHNYN
[1]
0.003759046
[2]
KH and NYN domain containing
[3]
1.077
[4]
1.064
[5]
1.091
[6]
<0.001
[9] array · 7 items
[0]
LSM12
[1]
0.001920731
[2]
LSM12 homolog
[3]
1.174
[4]
1.142
[5]
1.207
[6]
<0.001
[10] array · 7 items
[0]
PABPC3
[1]
0.046789802
[2]
poly(A) binding protein, cytoplasmic 3
[3]
1.371
[4]
1.299
[5]
1.446
[6]
<0.001
[11] array · 7 items
[0]
PNRC2
[1]
0.000388663
[2]
Proline-rich nuclear receptor coactivator 2
[3]
1.026
[4]
1.020
[5]
1.031
[6]
<0.001
[12] array · 7 items
[0]
RDM1
[1]
0.042431162
[2]
RAD52 motif 1 [Source:HGNC Symbol;Acc:19950]
[3]
1.552
[4]
1.439
[5]
1.674
[6]
<0.001
[13] array · 7 items
[0]
SPATS2L
[1]
0.008989807
[2]
Spermatogenesis associated, serine-rich 2-like
[3]
1.042
[4]
1.035
[5]
1.048
[6]
<0.001
[14] array · 7 items
[0]
TTF2
[1]
0.006389011
[2]
Transcription termination factor, RNA polymerase II
[3]
1.179
[4]
1.138
[5]
1.221
[6]
<0.001
locator
section[15]/table-wrap[1]#T2
gaps array · 0 items
analysis object · 4 fields
state
complete
methods array · 4 items
[0] object · 10 fields
id
method-1
family
survival_analysis
specific
cox_proportional_hazards
label
Survival analysis
dsl_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
1
band
verbatim
quote
As the training cohort, TCGA dataset was used to conduct univariate Cox regression analysis to screen for OS-related RBP genes in gliomas. A total of 662 OS-related RBP genes were identified (p < 0.05). Next, Lasso Cox regression method, a recommended method for regression of high-dimensional microarray data, was used to fit the OS-related RBPs data and construct a risk signature based on the selected 662 RBP genes.
[1] object · 10 fields
id
method-2
family
survival_analysis
specific
kaplan_meier
label
Survival analysis
dsl_operations array · 1 item
[0]
survival_km
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.8
band
high
quote
Kaplan-Meier
[2] object · 10 fields
id
method-3
family
survival_analysis
specific
log_rank_test
label
Survival analysis
dsl_operations array · 1 item
[0]
logrank_test
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.8
band
high
quote
log-rank
[3] object · 10 fields
id
method-4
family
diagnostic_evaluation
specific
roc
label
Diagnostic test evaluation
dsl_operations array · 6 items
[0]
confusion_counts
[1]
roc_curve
[2]
sensitivity_specificity
[3]
solve_confusion_matrix
[4]
classification_metrics
[5]
published_precision_envelope
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
reference_standard_and_test
evidence object · 3 fields
score
0.8
band
high
quote
ROC analysis
targets array · 0 items
gaps array · 0 items
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
blocked
tier
R4
blocked_on
data:accession_absent
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R4
reachable
false
accessions array · 0 items
resolved_accessions array · 0 items
statements array · 1 item
[0]
Publicly available datasets were analyzed in this study. This data can be found here: The data analyzed in this study can be acquired in the TCGA (http://cancergenome.nih.gov/), CGGA (http://www.cgga.org.cn/), and GEO (https://www.ncbi.nlm.nih.gov/geo/) websites.
basis
The paper names no accession to its source data, so the data has to come from the authors.
can_run object · 3 fields
dsl_operations array · 1 item
[0]
cox_ph
assets array · 3 items
[0]
source:pmid:33634092
[1]
asset:table:pmid:33634092:1
[2]
asset:table:pmid:33634092:2
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:None
gaps array · 1 item
[0]
data:accession_absent
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T19:26:12Z
independence
single_reader
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
3
usage object · 3 fields
prompt_tokens
25690
completion_tokens
2061
cached_tokens
784
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:33634092
type
paper
label
pmid:33634092
[1] object · 3 fields
id
source:pmid:33634092
type
manuscript
label
PMID 33634092 full text
[2] object · 3 fields
id
data:geo:None
type
dataset
label
GEO None
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:33634092
type
paper
label
pmid:33634092
[1] object · 3 fields
id
source:pmid:33634092
type
manuscript
label
PMID 33634092 full text
[2] object · 3 fields
id
data:geo:None
type
dataset
label
GEO None
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-33634092
type
extraction
used array · 1 item
[0]
source:pmid:33634092
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-None
type
accession_resolution
used array · 1 item
[0]
data:geo:None
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:33634092
parent_hash
sha256:fdfd0d97ce626f6db08a3174d9fac094bf0b328ba08a1a9ba55f34b613ccf77a
fork_of
null
gaps array · 5 items
[0]
execution.not_run
[1]
review.human_critique
[2]
review.independent_reader
[3]
review.machine_critique
[4]
step:obtain_source_data blocked on data:accession_absent
assays array · 2 items
[0] object · 11 fields
role
data_generation
definition_id
rna_seq
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 2 items
[0]
m the exclusion criterion, we obtained three RNA-seq cohorts (TCGA, CGGAseq1, and CGGAseq2) and o
[1]
in this study. Data Processing For the three RNA-seq cohorts, the Fragments Per Kilobase of trans
order_basis
paper_text_order:2389
id
assay:1
[1] object · 11 fields
role
analysis
definition_id
survival_analysis
definition_version
f2132e96ae6c7a4e
required_operations array · 1 item
[0]
cox_ph
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
As the training cohort, TCGA dataset was used to conduct univariate Cox regression analysis to screen for OS-related RBP genes in gliomas. A total of 662 OS-related RBP genes were identified (p < 0.05). Next, Lasso Cox regression method, a recommended method for regression of high-dimensional microarray data, was used to fit the OS-related RBPs data and construct a risk signature based on the selected 662 RBP genes.
order_basis
consumes_earlier_output
id
assay:2
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:33634092", "kind": "science-record", "revision": 7, "content_hash": "sha256:ccd6b4640759d1661fc02db19e997d7b4913d421982246916444b545a4be0d0f", "created_at": "2026-11-01T15:41:26Z", "updated_at": "2026-11-01T22:03:12Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients.", "doi": "10.3389/fcell.2020.588368", "pmid": "33634092", "authors": ["Zewei Tu", "Lei Shu", "Jingying Li", "Lei Wu", "Chuming Tao", "Minhua Ye", "Xingen Zhu", "Kai Huang"], "journal": "Frontiers in cell and developmental biology", "year": 2020, "abstract": "RNA binding proteins (RBPs) have been reported to be involved in cancer malignancy but related functions in glioma have been less studied. Herein, we screened 14 prognostic RBP genes and constructed a risk signature to predict the prognosis of glioma patients. Univariate Cox regression was used to identify overall survival (OS)-related RBP genes. Prognostic RBP genes were screened and used to establish the RBP-signature using the least absolute shrinkage and selection operator (Lasso) method in The Cancer Genome Atlas (TCGA) cohort. The 14 RBP genes signature showed robust and stable prognostic value in the TCGA training (n = 562) cohort and in three independent validation cohorts (Chinese Glioma Genome Atlas [CGGA]seq1, CGGAseq2, and GSE16011 datasets comprising 303, 619, and 250 glioma patients, respectively). Risk scores were calculated for each patient and high-risk gliomas were defined by the median risk score in each cohort. Survival analysis in subgroups of glioma patients showed that the RBP-signature retained its prognostic value in low-grade gliomas (LGGs) and glioblastomas (GBM)s. Univariate and multivariate Cox regression analysis in each dataset and the meta cohort revealed that the RBP-signature stratification could efficiently recognize high-risk gliomas [Hazard Ratio (HR):3.662, 95% confidence interval (CI): 3.187-4.208, p < 0.001] and was an independent prognostic factor for OS (HR:1.594, 95% CI: 1.244-2.043, p < 0.001). Biological process and KEGG pathway analysis revealed the RBP gene signature was associated with immune cell activation, the p53 signaling pathway, and the PI3K-Akt signaling pathway and so on. Moreover, a nomogram model was constructed for clinical application of the RBP-signature, which showed stable predictive ability. In summary, the RBP-signature could be a robust indicator for prognostic evaluation and identifying high-risk glioma patients.", "claims": [{"id": "claim-method", "statement": "As the training cohort, TCGA dataset was used to conduct univariate Cox regression analysis to screen for OS-related RBP genes in gliomas. A total of 662 OS-related RBP genes were identified (p < 0.05). Next, Lasso Cox regression method, a recommended method for regression of high-dimensional microarray data, was used to fit the OS-related RBPs data and construct a risk signature based on the selected 662 RBP genes.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:33634092", "locator": "sections[6] \"Construction of the RBP-Signature\" paragraph 2", "quote": "As the training cohort, TCGA dataset was used to conduct univariate Cox regression analysis to screen for OS-related RBP genes in gliomas. A total of 662 OS-related RBP genes were identified (p < 0.05). Next, Lasso Cox regression method, a recommended method for regression of high-dimensional microarray data, was used to fit the OS-related RBPs data and construct a risk signature based on the selected 662 RBP genes."}], "state": "complete"}, {"id": "claim-data-access", "statement": "Publicly available datasets were analyzed in this study. This data can be found here: The data analyzed in this study can be acquired in the TCGA (http://cancergenome.nih.gov/), CGGA (http://www.cgga.org.cn/), and GEO (https://www.ncbi.nlm.nih.gov/geo/) websites.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:33634092", "locator": "sections[20] \"Data Availability Statement\" paragraph 2", "quote": "Publicly available datasets were analyzed in this study. This data can be found here: The data analyzed in this study can be acquired in the TCGA (http://cancergenome.nih.gov/), CGGA (http://www.cgga.org.cn/), and GEO (https://www.ncbi.nlm.nih.gov/geo/) websites."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "partial", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:33634092"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "blocked", "blocked_on": "data:accession_absent", "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:obtain_source_data blocked on data:accession_absent"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:33634092", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.3389/fcell.2020.588368", "sha256": "sha256:be85b9d7dc3ce7962a39d8c0ae2fcc3d31ebe4c72364cefa3f9268c5a6d8d06d", "bytes": 33399, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.3389/fcell.2020.588368", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC7901892", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "asset:table:pmid:33634092:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:6108ddace2d5cff7a6dd995ffdc1891020d14c9eb11012c2c33fbc22ffdbe2ff", "bytes": 2285, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[4]/table-wrap[1]#T1", "version": null, "note": "Clinicopathological and molecular information of glioma patients included in this study.", "structure": {"pmcid": "PMC7901892", "section_index": 4, "section_title": "Patient Exclusion Criterion", "row_count": 31, "column_count": 6}, "table": {"label": "Table 1", "caption": "Clinicopathological and molecular information of glioma patients included in this study.", "rows": [["Features", "Total", "TCGA cohort", "CGGAseq1 cohort", "CGGAseq2 cohort", "GSE16011 cohort"], ["", "(n = 1,734)", "(n = 562)", "(n = 303)", "(n = 619)", "(n = 250)"], ["Overall survival (years)"], ["Median (range)", "1.54 (0.08–20.68)", "1.18 (0.08–17.34)", "2.22 (0.09–11.41)", "2.16 (0.11–11.98)", "1.27 (0.08–20.68)"], ["<5", "1,428 (82.4%)", "512 (91.1%)", "201 (66.3%)", "509 (82.2%)", "206 (82.4%)"], ["≥5", "306 (17.6%)", "50 (8.9%)", "102 (33.7)", "110 (69%)", "44 (17.6%)"], ["Age (years)"], ["Median (range)", "45 (8–87)", "47.5 (14–87)", "42 (8–79)", "43 (11–76)", "51.5 (14–81)"], ["<40", "617 (35.6%)", "197 (35.1%)", "119 (39.3%)", "235 (38.0%)", "66 (26.4%)"], ["≥40", "1,115 (64.3%)", "365 (64.9%)", "184 (60.7%)", "383 (61.9%)", "183 (73.2%)"], ["NA", "2 (0.1%)", "0 (0.0%)", "0 (0.0%)", "1 (0.2%)", "1 (0.4%)"], ["Gender"], ["Male", "1,035 (59.7%)", "326 (58.0%)", "187 (61.7%)", "356 (57.5%)", "166 (66.4%)"], ["Female", "699 (40.3%)", "236 (42.0%)", "116 (38.3%)", "263 (43.5%)", "84 (33.6%)"], ["WHO grade"], ["II", "488 (28.1%)", "196 (34.9%)", "97 (32.0%)", "173 (27.9%)", "22 (8.8%)"], ["III", "598 (34.5%)", "212 (37.7%)", "73 (24.1%)", "232 (37.5%)", "81 (32.4%)"], ["IV", "648 (37.4%)", "154 (27.4%)", "133 (43.9%)", "214 (34.6)", "147 (58.8%)"], ["Histology"], ["Astrocytoma", "401 (23.1%)", "150 (26.7%)", "62 (20.5%)", "163 (26.3%)", "26 (10.4%)"], ["Oligoastrocytoma", "414 (23.9%)", "102 (18.1%)", "72 (23.8%)", "213 (34.4%)", "27 (10.8%)"], ["Oligodendroglioma", "271 (15.6%)", "156 (27.8%)", "36 (11.9%)", "29 (4.7%)", "50 (20.0%)"], ["Glioblastoma", "648 (37.4%)", "154 (27.4%)", "133 (43.9%)", "214 (34.6%)", "147 (58.8%)"], ["IDH mutation status"], ["6 Mutant", "823 (47.5%)", "342 (60.9%)", "165 (54.5%)", "316 (51.1%)", "NA"], ["Wild", "304 (17.5%)", "212 (37.7%)", "137 (45.2%)", "258 (41.7%)", "NA"], ["NA", "607 (35.0%)", "8 (1.4%)", "1 (0.3%)", "45 (7.3%)", "NA"], ["1p/19q codeletion status"], ["Non-codeletion", "1,080 (62.3%)", "418 (74.4%)", "235 (77.6%)", "427 (69.0%)", "NA"], ["Codeletion", "329 (19.0%)", "138 (24.6%)", "63 (20.8%)", "128 (20.7%)", "NA"], ["NA", "325 (18.7%)", "6 (1.1%)", "5 (1.7%)", "64 (10.3%)", "NA"]], "row_count": 31, "column_count": 6, "numeric_cells": 116, "header_rows": 2, "locator": "section[4]/table-wrap[1]#T1"}}, {"id": "asset:table:pmid:33634092:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:5a707bb2f8d918ebd5241aaebf23477b7380ed191d019ca0c243c4deb58360a3", "bytes": 1690, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[15]/table-wrap[1]#T2", "version": null, "note": "Coeffients and univariate Cox regression analysis of 14 RBP genes.", "structure": {"pmcid": "PMC7901892", "section_index": 15, "section_title": "The Prognostic Value and Expression Levels of the 14 RBPs in Gliomas", "row_count": 15, "column_count": 7}, "table": {"label": "Table 2", "caption": "Coeffients and univariate Cox regression analysis of 14 RBP genes.", "rows": [["Gene", "Coeffients", "Description", "HR", "HR.95L", "HR.95H", "p-value"], ["CTIF", "−0.002890097", "CBP80/20-dependent translation initiation factor", "0.953", "0.944", "0.961", "<0.001"], ["GNL1", "−0.00776999", "Guanine nucleotide binding protein-like 1", "0.965", "0.959", "0.971", "<0.001"], ["ANG", "0.007044793", "Angiogenin, ribonuclease, RNase A family, 5", "1.083", "1.068", "1.099", "<0.001"], ["APOBEC3F", "0.016648735", "Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F", "1.307", "1.256", "1.360", "<0.001"], ["CARHSP1", "0.0000186", "Calcium regulated heat stable protein 1", "1.024", "1.019", "1.029", "<0.001"], ["FBXO17", "0.02126961", "F-box protein 17", "1.071", "1.060", "1.082", "<0.001"], ["ISG20", "0.024346644", "Interferon stimulated exonuclease gene 20kDa", "1.173", "1.143", "1.203", "<0.001"], ["KHNYN", "0.003759046", "KH and NYN domain containing", "1.077", "1.064", "1.091", "<0.001"], ["LSM12", "0.001920731", "LSM12 homolog", "1.174", "1.142", "1.207", "<0.001"], ["PABPC3", "0.046789802", "poly(A) binding protein, cytoplasmic 3", "1.371", "1.299", "1.446", "<0.001"], ["PNRC2", "0.000388663", "Proline-rich nuclear receptor coactivator 2", "1.026", "1.020", "1.031", "<0.001"], ["RDM1", "0.042431162", "RAD52 motif 1 [Source:HGNC Symbol;Acc:19950]", "1.552", "1.439", "1.674", "<0.001"], ["SPATS2L", "0.008989807", "Spermatogenesis associated, serine-rich 2-like", "1.042", "1.035", "1.048", "<0.001"], ["TTF2", "0.006389011", "Transcription termination factor, RNA polymerase II", "1.179", "1.138", "1.221", "<0.001"]], "row_count": 15, "column_count": 7, "numeric_cells": 87, "header_rows": 1, "locator": "section[15]/table-wrap[1]#T2"}}], "gaps": []}, "analysis": {"state": "complete", "methods": [{"id": "method-1", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "As the training cohort, TCGA dataset was used to conduct univariate Cox regression analysis to screen for OS-related RBP genes in gliomas. A total of 662 OS-related RBP genes were identified (p < 0.05). Next, Lasso Cox regression method, a recommended method for regression of high-dimensional microarray data, was used to fit the OS-related RBPs data and construct a risk signature based on the selected 662 RBP genes."}}, {"id": "method-2", "family": "survival_analysis", "specific": "kaplan_meier", "label": "Survival analysis", "dsl_operations": ["survival_km"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "Kaplan-Meier"}}, {"id": "method-3", "family": "survival_analysis", "specific": "log_rank_test", "label": "Survival analysis", "dsl_operations": ["logrank_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "log-rank"}}, {"id": "method-4", "family": "diagnostic_evaluation", "specific": "roc", "label": "Diagnostic test evaluation", "dsl_operations": ["confusion_counts", "roc_curve", "sensitivity_specificity", "solve_confusion_matrix", "classification_metrics", "published_precision_envelope"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["reference_standard_and_test"], "evidence": {"score": 0.8, "band": "high", "quote": "ROC analysis"}}], "targets": [], "gaps": []}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "data", "blocked_on": "data:accession_absent", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["cox_ph"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R4", "reachable": false, "accessions": [], "resolved_accessions": [], "statements": ["Publicly available datasets were analyzed in this study. This data can be found here: The data analyzed in this study can be acquired in the TCGA (http://cancergenome.nih.gov/), CGGA (http://www.cgga.org.cn/), and GEO (https://www.ncbi.nlm.nih.gov/geo/) websites."], "basis": "The paper names no accession to its source data, so the data has to come from the authors."}}, "can_run": {"dsl_operations": ["cox_ph"], "assets": ["source:pmid:33634092", "asset:table:pmid:33634092:1", "asset:table:pmid:33634092:2"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:None"]}, "gaps": ["data:accession_absent"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T19:26:12Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 3, "usage": {"prompt_tokens": 25690, "completion_tokens": 2061, "cached_tokens": 784}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:33634092", "type": "paper", "label": "pmid:33634092"}, {"id": "source:pmid:33634092", "type": "manuscript", "label": "PMID 33634092 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:33634092", "type": "paper", "label": "pmid:33634092"}, {"id": "source:pmid:33634092", "type": "manuscript", "label": "PMID 33634092 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-33634092", "type": "extraction", "used": ["source:pmid:33634092"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-None", "type": "accession_resolution", "used": ["data:geo:None"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:33634092", "parent_hash": "sha256:fdfd0d97ce626f6db08a3174d9fac094bf0b328ba08a1a9ba55f34b613ccf77a", "fork_of": null, "generation": 6}, "gaps": ["execution.not_run", "review.human_critique", "review.independent_reader", "review.machine_critique", "step:obtain_source_data blocked on data:accession_absent"], "assays": [{"role": "data_generation", "definition_id": "rna_seq", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["m the exclusion criterion, we obtained three RNA-seq cohorts (TCGA, CGGAseq1, and CGGAseq2) and o", "in this study. Data Processing For the three RNA-seq cohorts, the Fragments Per Kilobase of trans"], "order_basis": "paper_text_order:2389", "id": "assay:1"}, {"role": "analysis", "definition_id": "survival_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["cox_ph"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["As the training cohort, TCGA dataset was used to conduct univariate Cox regression analysis to screen for OS-related RBP genes in gliomas. A total of 662 OS-related RBP genes were identified (p < 0.05). Next, Lasso Cox regression method, a recommended method for regression of high-dimensional microarray data, was used to fit the OS-related RBPs data and construct a risk signature based on the selected 662 RBP genes."], "order_basis": "consumes_earlier_output", "id": "assay:2"}]}